Article
Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
Vascular medicine (London, England) - 1 Aug 2013
Lind Lars, Ingelsson Erik, Kumar Jitender, Syvänen Ann-Christine, Axelsson Tomas, Teerlink Tom
Abstract excerpt
OBJECTIVES: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide synthase. The breakdown of ADMA is mainly governed by the activity of dimethylarginine dimethylaminohydrolases (DDAHs). We investigated if genetic variation in the DDAH1 and DDAH2 genes were related to ADMA and l-arginine levels, as well as measures of endothelium-dependent vasodilation. METHODS: In 1016 70-year-old...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
